Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID

Overview

Journal J Pain Res

Publisher Dove Medical Press

Date 2022 Jun 24

PMID 35747600

Authors

Omar Khoja

Barbara Silva Passadouro

Matthew Mulvey

Ioannis Delis

Sarah Astill

Ai Lyn Tan

Manoj Sivan

Affiliations

Soon will be listed here.

Abstract

Objective: Musculoskeletal (MSK) pain is being increasingly reported by patients as one of the most common persistent symptoms in post-COVID-19 syndrome or Long COVID. However, there is a lack of understanding of its prevalence, characteristics, and underlying pathophysiological mechanisms. The objective of this review is to identify and describe the features and characteristics of MSK pain in Long COVID patients.

Methods: The narrative review involved a literature search of the following online databases: MEDLINE (OVID), EMBASE (OVID), CINAHL, PsyclNFO, and Web of Science (December 2019 to February 2022). We included observational studies that investigated the prevalence, characteristics, risk factors and mechanisms of MSK pain in Long COVID. After screening and reviewing the initial literature search results, a total of 35 studies were included in this review.

Results: The overall reported prevalence of MSK pain in Long COVID ranged widely from 0.3% to 65.2%. The pain has been reported to be localized to a particular region or generalized and widespread. No consistent pattern of progression of MSK pain symptoms over time was identified. Female gender and higher BMI could be potential risk factors for Long COVID MSK pain, but no clear association has been found with age and ethnicity. Different pathophysiological mechanisms have been hypothesized to contribute to MSK pain in Long COVID including increased production of proinflammatory cytokines, immune cell hyperactivation, direct viral entry of neurological and MSK system cells, and psychological factors.

Conclusion: MSK pain is one of the most common symptoms in Long COVID. Most of the current literature on Long COVID focuses on reporting the prevalence of persistent MSK pain. Studies describing the pain characteristics are scarce. The precise mechanism of MSK pain in Long COVID is yet to be investigated. Future research must explore the characteristics, risk factors, natural progression, and underlying mechanisms of MSK pain in Long COVID.

Citing Articles

Transcutaneous electrical nerve stimulation for fibromyalgia-like syndrome in patients with Long-COVID: a pilot randomized clinical trial.

Zulbaran-Rojas A, Bara R, Lee M, Bargas-Ochoa M, Phan T, Pacheco M Sci Rep. 2024; 14(1):27224.

PMID: 39516528 PMC: 11549448. DOI: 10.1038/s41598-024-78651-5.

Distinguishing pain profiles among individuals with long COVID.

Tabacof L, Chiplunkar M, Canori A, Howard R, Wood J, Proal A Front Rehabil Sci. 2024; 5:1448816.

PMID: 39493003 PMC: 11527737. DOI: 10.3389/fresc.2024.1448816.

New-Onset Chronic Musculoskeletal Pain Following COVID-19 Infection Fulfils the Fibromyalgia Clinical Syndrome Criteria: A Preliminary Study.

Khoja O, Mulvey M, Astill S, Tan A, Sivan M Biomedicines. 2024; 12(9).

PMID: 39335454 PMC: 11429044. DOI: 10.3390/biomedicines12091940.

Impact of Spa Therapy on Symptoms and Quality of Life in Post-COVID-19 Patients with Chronic Conditions.

Costantino M, Giudice V, Farroni M, Marongiu F, De Caro F, Filippelli A J Clin Med. 2024; 13(17).

PMID: 39274303 PMC: 11396595. DOI: 10.3390/jcm13175091.

Clinical Characterization of New-Onset Chronic Musculoskeletal Pain in Long COVID: A Cross-Sectional Study.

Khoja O, Silva-Passadouro B, Cristescu E, McEwan K, Doherty D, OConnell F J Pain Res. 2024; 17:2531-2550.

PMID: 39100135 PMC: 11298172. DOI: 10.2147/JPR.S466294.

References

McWilliams L, Cox B, Enns M . Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003; 106(1-2):127-33. DOI: 10.1016/s0304-3959(03)00301-4. View

Taquet M, Dercon Q, Luciano S, Geddes J, Husain M, Harrison P . Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021; 18(9):e1003773. PMC: 8478214. DOI: 10.1371/journal.pmed.1003773. View

Zhou M, Cai J, Sun W, Wu J, Wang Y, Gamber M . Do post-COVID-19 symptoms exist? A longitudinal study of COVID-19 sequelae in Wenzhou, China. Ann Med Psychol (Paris). 2021; 179(9):818-821. PMC: 7934689. DOI: 10.1016/j.amp.2021.03.003. View

Jacobson K, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M . Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clin Infect Dis. 2021; 73(3):e826-e829. PMC: 7929039. DOI: 10.1093/cid/ciab103. View

Sivan M, Parkin A, Makower S, Greenwood D . Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross-sectional evaluation from a community COVID rehabilitation service. J Med Virol. 2021; 94(4):1419-1427. PMC: 8661751. DOI: 10.1002/jmv.27456. View

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

Muus C, Luecken M, Eraslan G, Sikkema L, Waghray A, Heimberg G . Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat Med. 2021; 27(3):546-559. PMC: 9469728. DOI: 10.1038/s41591-020-01227-z. View

Cieza A, Causey K, Kamenov K, Wulf Hanson S, Chatterji S, Vos T . Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10267):2006-2017. PMC: 7811204. DOI: 10.1016/S0140-6736(20)32340-0. View

Soares F, Kubota G, Fernandes A, Hojo B, Couras C, Costa B . Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur J Pain. 2021; 25(6):1342-1354. PMC: 8013219. DOI: 10.1002/ejp.1755. View

10.

Mailhot B, Christin M, Tessandier N, Sotoudeh C, Bretheau F, Turmel R . Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases. J Exp Med. 2020; 217(9). PMC: 7478735. DOI: 10.1084/jem.20191430. View

11.

Mohammed Mohiuddin Chowdhury A, Karim M, Ali M, Islam J, Li Y, He S . Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients-A Prospective Multicenter Cross-Sectional Study. Front Med (Lausanne). 2021; 8:663670. PMC: 8416537. DOI: 10.3389/fmed.2021.663670. View

12.

Cascella M, Del Gaudio A, Vittori A, Bimonte S, Prete P, Forte C . COVID-Pain: Acute and Late-Onset Painful Clinical Manifestations in COVID-19 - Molecular Mechanisms and Research Perspectives. J Pain Res. 2021; 14:2403-2412. PMC: 8364364. DOI: 10.2147/JPR.S313978. View

13.

Greenhalgh T, Knight M, ACourt C, Buxton M, Husain L . Management of post-acute covid-19 in primary care. BMJ. 2020; 370:m3026. DOI: 10.1136/bmj.m3026. View

14.

Starkweather A, Heineman A, Storey S, Rubia G, Lyon D, Greenspan J . Methods to measure peripheral and central sensitization using quantitative sensory testing: A focus on individuals with low back pain. Appl Nurs Res. 2016; 29:237-41. DOI: 10.1016/j.apnr.2015.03.013. View

15.

Fernandez-de-Las-Penas C, Gomez-Mayordomo V, Cuadrado M, Palacios-Cena D, Florencio L, Guerrero A . The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study. Cephalalgia. 2021; 41(13):1332-1341. PMC: 8212025. DOI: 10.1177/03331024211020404. View

16.

Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020; 93(2):1013-1022. DOI: 10.1002/jmv.26368. View

17.

Salmon-Ceron D, Slama D, de Broucker T, Karmochkine M, Pavie J, Sorbets E . Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study. J Infect. 2020; 82(2):e1-e4. PMC: 7833274. DOI: 10.1016/j.jinf.2020.12.002. View

18.

Sykes D, Holdsworth L, Jawad N, Gunasekera P, Morice A, Crooks M . Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?. Lung. 2021; 199(2):113-119. PMC: 7875681. DOI: 10.1007/s00408-021-00423-z. View

19.

Wong A, Demediuk L, Tay J, Wawryk O, Collins A, Everitt R . COVID-19 end-of-life care: symptoms and supportive therapy use in an Australian hospital. Intern Med J. 2021; 51(9):1420-1425. PMC: 8250873. DOI: 10.1111/imj.15300. View

20.

Lu Y, Li X, Geng D, Mei N, Wu P, Huang C . Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study. EClinicalMedicine. 2020; 25:100484. PMC: 7396952. DOI: 10.1016/j.eclinm.2020.100484. View